Anavex Life Sciences holds annual shareholder meeting; 54,239,204 shares represented by proxy
AVXL•Anavex Life Sciences held its annual stockholders meeting on Sept. 24, 2026, with 54,239,204 shares represented by proxy. Stockholders backed a contested board refresh, triggering a change-in-control provision that immediately vested outstanding unvested equity awards under the company’s omnibus incentive plans.
1. Meeting triggers vesting
Anavex said stockholders backed a contested board refresh at its Sept. 24 annual meeting. The resulting change in control under the company’s omnibus incentive plans and a senior finance employment agreement took effect, causing all outstanding unvested equity awards under those plans to vest immediately and become exercisable.
